Published in Cancer Weekly, September 24th, 2002
Researchers led by the National Cancer Institute measured the risk of these "second cancers" among Hodgkin disease survivors using data from cancer registries in the U.S., Canada, and four Nordic countries. The research, published in the Journal of Clinical Oncology tracked cancer incidence and had among the longest follow-up periods of any study to date. Of the study population, 1111 patients were followed for 25 years or longer.
The study found...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.